NCT02297139 2023-05-06Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating DasatinibBristol-Myers SquibbPhase 2 Completed17 enrolled 12 charts
NCT03161613 2022-05-27Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in MexicoBristol-Myers SquibbWithdrawn